The ®rst two articles discussed how to formulate and pursue clinical questions and how to build a clinical reference library. Looking up clinical questions during or immediately after patient care can be an effective method of learning: however, you must ®rst realize your ignorance, then formulate a searchable question, ®nd the answer and change your practice as a result. Even when there is widespread knowledge about an important innovation in clinical practice, such as aspirin for patients with myocardial infarction (MI), many patients are still incorrectly managed. Practice guidelinesÐ`systematically developed advisory statements created according to validated methodologies' 1 Ðact as a compact summary of the evidence and other factors guiding patient management so could be helpful in this context, but they are many and various 2, 3 .
HOW TO SELECT A GUIDELINE
Your consultant asks you to identify a guideline to increase the local use of aspirin after MI As a perfectionist, you want to select the very best from the multitude of guidelines on management of MI. But what makes a good-quality guideline? Italian workers have proposed three criteria: whether the guideline (a) reports the range of professionals involved in development, (b) reports the strategy used to identify primary evidence and (c) explicitly grades the recommendations 2 . Inspection of 431 specialty society guidelines published from 1988 to 1998 showed that 54% met none of the criteria, 34% met one, 7% met two and only 5% met all three. Seemingly, specialty guidelines have been dominated by`experts', with little involvement of GPs and other users. Equally, most guidelines result from an informal me Âlange of opinion in the charged social atmosphere of a committee. One encouraging result in the Italian review was that the more recent guidelines were more likely to include details of literature search and graded recommendations.
A UK group has developed a checklist of thirty-seven questions exploring three dimensions (rigour of development, clarity of content and context, documentation of methods for application and monitoring) [www.sghms. ac.uk/phs/hceu/]. In a study in which six clinicians used this`St George's checklist' to assess 60 guidelines the interrater agreement was excellent 4 . However, even if a guideline is of high scienti®c quality, doctors may still not follow it. An observational study of Dutch clinicians suggested that key determinants of whether recommendations would be followed were that they were uncontroversial, speci®c, evidence-based and required no change to existing routine 5 .
Even when we locate a satisfactory published guideline, it often proves too bulky or inconvenient for use in routine patient care. Some guideline authors now offer support tools such as glossy laminated¯owcharts, pocket prompt cards or wall posters. Such tools are discussed later.
HOW TO MAKE A GUIDELINE LOCALLY RELEVANT
Guidelines nearly always contain recommendations that cannot be universally adopted. For instance, certain tests or treatments may not be locally available, or a recommendation for specialist care may run counter, without supporting evidence, to a local tradition of community care. Thus, a national guideline commonly needs to be adapted if local clinicians are to get a feeling of`ownership'. Strategies can include:
. Summarizing the guideline in a standard short format for a house of®cers' handbook . Deleting the sections that do not apply locally (if there is no strong evidence that they should be retained) . Adding information about local facilities and services, such as to whom to refer patients, which days the clinic takes place and what phone number to ring.
However, sometimes when scrutinizing and tailoring a guideline one realizes that the raw material is unsatisfactory and a new one is needed.
HOW TO WRITE A NEW GUIDELINE
After applying the St George's checklist to ®ve guidelines on aspirin in MI, you ®nd that none is satisfactory. You resign yourself to writing a de®nitive guideline
Writing a high-quality guideline is hard, especially if you mean it to score well on the St George's checklist 4 . Before writing a single recommendation you will have to set up a multidisciplinary group, conduct detailed searches, appraise and grade the evidence, and combine this with other information such as patient preferences and health economic data. Various bodies, including the Scottish Inter-collegiate Guideline Network [www.sign.ac.uk] 8 and the North of England Group 9 , have developed and published rigorous methods. Lessons from such activities are that adherence to the methodology depends not only on clinical commitment but also on library and epidemiological support, that the evidence tends to be more abundant than expected but much of it is of low quality, and that the effort of reaching agreement is about twice that envisaged. You decide to go ahead; but you are stopped in your tracks by your clinical director who asks about the legal implications for guideline users, authors and publishers.
What is the legal position of guideline users and authors?
Despite worries that the introduction of guidelines would lead to a¯ood of negligence cases, guidelines play a part in only 7% of US malpractice claims. However, there is a suf®cient body of cases to allow some general conclusions 10, 11 .
Differences between clinical and legal views
Guidelines are created for a medical purpose, so have no special legal status. To a doctor, practice guidelines are clinical guidance resting ®rmly on the authority of science. To a lawyer, a guideline advises health professionals to practise in one way rather than another. Courts are always wary of guidance that cannot be subjected to crossexamination; so, although guidelines may be used in court to support a negligence case, they cannot substitute for expert testimony. An expert witness is necessary to help the court interpret the relevance of a guideline, even when its recommendations are found to be representative of responsible practice. Thus, the legal status of each guideline must be decided afresh in each case 10 .
Liability of authors and publishers
As a matter of public policy and to encourage the dissemination of knowledge, book authors and publishers are`never' found liable for negligence due to errors 12 . However, guidelines may be treated differently 10 . There have been no UK negligence cases yet, but in American courts the developers have been held liable for faulty guidelines. Commenting on the relevance of this to the UK, Hurwitz wrote:`There appears to be no logical reason why similar liability could not attach to the originators and issuers of UK guidelines shown to cause patient harm as a result of faulty guideline development methods '10 . Failure of the guideline user to protest about the guideline does not protect the developer from a claim of negligence. Even if patients generally fail in suing guideline authors, other parties (such as a company whose product is disadvantaged) may bring a case 11 . Guidelines are merely advice, so the language used should encourage and remind clinicians to exercise appropriate discretion, for example avoiding words such as`never' and`always' 10 . However, use of permissive language (`probably',`sometimes') when directive terminology is more appropriate may not protect the developers from liability. Such permissive language would be troublesome if it encouraged users to assume that other actions were appropriate in circumstances when the evidence supported only one course of action.
Liability of doctors for adherence
Adherence to a guideline is not automatically evidence of reasonable clinical practice, so doctors cannot escape legal liability by claiming that adherence to a guideline has overridden their clinical judgment 10 . In the UK, even if a guideline has been agreed as a legal standard, appropriate application still requires discretion. For example, a Scottish man with congenital homonymous quadrantanopia successfully appealed for restoration of his driving licence even though it had been withdrawn on the basis of legally adopted guidelines. A clinician who complies without protest with an inappropriate guideline cannot then deny responsibility for patient harm. The test of reasonableness of medical treatment remains`the standard of the ordinary skilled man exercising and professing to have that special skill . . . who acted in accordance with a practice accepted as proper by a reasonable body of medical men skilled in that particular art' 13 .
Liability of doctors for non-adherence
In determining the status of a particular guideline, courts are likely to consider its authority,¯exibility and scope, whether its development and application had statutory backing, and whether it embodies practices accepted as proper by a responsible body of doctors. Clinical practice may be perfectly lawful when it does not comply with a guideline, even one issued with executive authority. As Lord President Clyde stated in 1957,`There is ample scope for genuine difference of opinion and one man is not negligent merely because his conclusion differs from that of other professional men' 10 Business process re-engineering Analysing the fundamental aims of an organization and how best to meet them recent innovations in clinical science. However, the existence of such a guideline does not make every clinician liable. Lord Denning stated in 1955 that`It would be quite wrong to suggest a medical man is negligent because he does not at once put into operation the suggestion that some contributor or other might make in a medical journal' 10 . Guidelines designed to hasten the adoption of recent evidence would not re¯ect customary professional care.
Once your guideline group has taken these lessons to heart, it moves fast to produce a high-quality guideline which you succeed in publishing in a journal. The major question, now, is how to ensure that your guideline exerts the desired effects on clinical practice.
HOW TO PROMOTE A CLINICAL INNOVATION
You spend a year developing a de®nitive guideline on aspirin and MI which you publish in a journal and also circulate locally. However, six months later local clinicians are still not advising patients to take aspirin after MI Publication in a journal or circulation by mail is seldom suf®cient 14, 15 . Part of the challenge is to get clinicians to read the guideline, and strategies include ®ling a summary of the recommendations in patient notes, producing a summary card for clinic room desks or a wall poster, composing a page for the junior doctors' handbook, and making slides for continuing education. Techniques less speci®c to guidelines 16 . Re-engineer care processes to make errors less likely, e.g. staff substitution, redesigned records and request forms ®nancial incentives and use of opinion leaders (see Box 1 for de®nitions). Before the innovator can select the appropriate technique or combination of techniques, he or she must understand the barriers to change. Some clinicians may need to be persuaded or actually helped to do what is recommended; moreover, waverers will require continuing encouragement if they are to persevere with the innovation in the face of counter-pressure from patients 17 or peers. These stages are summarized in the PRECEDE model 18 Ð predisposing people to innovation, enabling the innovation and reinforcing the innovation ( Table 1) .
Identi®cation of barriers to innovation requires an understanding of where each individual or group lies in the innovation process and is fundamental to selection of appropriate techniques. Methods such as outreach visits 19 contain multiple elements effective against many barriers. As with broad-spectrum antibiotics we can say that they often work though we seldom know exactly why. Innovation techniques can be expensive and have serious unwanted effects. Again as with antibiotics, precise diagnosis beforehand will help in choice of a suitable agent. Table 1 links the three innovation stages, some speci®c barriers at each stage and appropriate techniques.
Effectiveness
A dif®culty in determining the effectiveness of an innovation technique is the large number of variables. For example, the intended result may be to introduce a new procedure or to lessen use of an outmoded one. The clinical behaviour targeted may be ordering of laboratory tests (to aid diagnosis 20 , screening or disease monitoring), prescribing, referral, hospital discharge or counselling 21 . A technique which works well in one of these areas may not be effective in another. Techniques may be used singly or in combination, and with or without an attempt to identify the barriers to innovation. A systematic review of 99 randomized trials, examining 160 innovation techniques 16 , indicated that 70% of techniques improved clinical practice and 48% improved patient outcomes. A rough idea of the effectiveness of these innovation methods along four dimensions can be had from Table 2 , though the comparisons are almost never within a single study and the number of studies is often too small to provide a reliable estimate.
The next article will examine continuing education activity in more detail; patient information will be discussed in article 6 and decision support systems in article 9. 
